Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 10, 2019 Off

Acerus Provides Business Update on NATESTO®

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) announced today an update relative to the Company’s…

July 10, 2019 Off

Horizon Therapeutics plc Submits Teprotumumab Biologics License Application (BLA) for the Treatment of Active Thyroid Eye Disease (TED)

By BusinessWire

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has submitted a Biologics License Application (BLA) to the U.S.…

July 10, 2019 Off

GVK BIO Announces Appointment of Robert R. Ruffolo, Ph.D., to its Board of Directors

By BusinessWire

HYDERABAD, India–(BUSINESS WIRE)–#ContractResearchandDevelopment–GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of…

July 10, 2019 Off

Merck Highlights Commitment to HIV Research with Presentations for Investigational Anti-HIV Agent MK-8591 at IAS 2019

By BusinessWire

Data Include Week 48 Results from Phase 2B Study Evaluating MK-8591 in Combination with Doravirine KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:…

July 10, 2019 Off

Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth

By BusinessWire

‒ Plan expected to reduce costs by approximately $50 million annually ‒ ‒ Reduces Full Year 2019 Adjusted EBITDA Guidance…

July 10, 2019 Off

Top 5 Vendors in the Cancer Biologics Market from 2019 to 2023 | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Biotechnology–Vendors in the cancer biologics market have significantly increased investments for the development of cancer treating biologic molecules. Consequently,…

July 10, 2019 Off

Osivax Secures EUR 8 Million of Financing through a Series A Round to Develop Novel Universal Flu Vaccines and Expand oligoDOM® Technology Platform

By BusinessWire

— Company to establish new subsidiary office in Liege, Belgium — LYON, France–(BUSINESS WIRE)–Osivax announced today that it has secured…

July 10, 2019 Off

Top 5 Vendors in the Addison’s Disease Therapeutics Market from 2019 to 2023 | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Biotechnology–The advantages of modified versions over conventional dosage forms are encouraging several companies to focus on developing modified versions…

July 10, 2019 Off

CMIC Joins Align Clinical CRO to Help Develop Open Technology Standards That Streamline Clinical Trials

By BusinessWire

TOKYO–(BUSINESS WIRE)–#CRO–CMIC Group, a pioneer and a leading CRO (Contract Research Organizations) in Japan, is pleased to announce that the…

July 9, 2019 Off

IQVIA to Announce Second-Quarter 2019 Results on July 24, 2019

By BusinessWire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will announce its second-quarter 2019 financial results before…

Posts pagination

Previous 1 … 3,017 3,018 3,019 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine